Epithelial-mesenchymal transition classification based on machine learning for predicting prognosis and treatment response in clear cell renal cell carcinoma
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Methods and Results: ten algorithms generated 101 models; CoxBoost+elastic net signature on TCGA then tested in E-MTAB-1980. Prognostic stratification and modeled drug-response differences are retrospective computational evidence.
Technology: Methods name the learned image/gene-expression model and its input-operation tied to the reported result.
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Methods name the learned image/gene-expression model and its input-operation tied to the reported result.
- Limitation / still unknown
- The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/139897/public/139897-PB14-4816-R6.pdf · https://pubmed.ncbi.nlm.nih.gov/40687644/
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.